R. Kohnen

484 total citations
17 papers, 317 citations indexed

About

R. Kohnen is a scholar working on Pharmacology, Psychiatry and Mental health and Cellular and Molecular Neuroscience. According to data from OpenAlex, R. Kohnen has authored 17 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 5 papers in Psychiatry and Mental health and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in R. Kohnen's work include Treatment of Major Depression (8 papers), Sexual function and dysfunction studies (3 papers) and Tryptophan and brain disorders (2 papers). R. Kohnen is often cited by papers focused on Treatment of Major Depression (8 papers), Sexual function and dysfunction studies (3 papers) and Tryptophan and brain disorders (2 papers). R. Kohnen collaborates with scholars based in Germany, Austria and Australia. R. Kohnen's co-authors include Michael Philipp, Otto Benkert, Ulrich Hegerl, Roland Mergl, Antje‐Kathrin Allgaier, Verena Henkel, Hans‐Jürgen Möller, Dina Baier, J. W. G. Tiller and G. A. Lienert and has published in prestigious journals such as Psychopharmacology, Psychiatry Research and Journal of Neurology.

In The Last Decade

R. Kohnen

16 papers receiving 287 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Kohnen Germany 9 156 141 51 44 44 17 317
Stephen T.H. Sokolov Canada 11 149 1.0× 172 1.2× 56 1.1× 31 0.7× 45 1.0× 13 370
Alana M. Burns United States 6 127 0.8× 164 1.2× 49 1.0× 26 0.6× 82 1.9× 7 309
Helen Jeffriess United States 8 158 1.0× 116 0.8× 51 1.0× 32 0.7× 55 1.3× 9 324
H.-J. Möller Germany 10 178 1.1× 95 0.7× 61 1.2× 43 1.0× 34 0.8× 26 340
Petros Malitas Greece 10 130 0.8× 36 0.3× 53 1.0× 57 1.3× 63 1.4× 17 349
Gillian Campling United Kingdom 11 51 0.3× 82 0.6× 29 0.6× 69 1.6× 49 1.1× 21 414
Victor Bancila Switzerland 9 77 0.5× 83 0.6× 23 0.5× 91 2.1× 40 0.9× 13 339
Ilaria Matarazzo Italy 10 138 0.9× 86 0.6× 36 0.7× 56 1.3× 135 3.1× 19 387
Manoochehr Khatami United States 6 82 0.5× 68 0.5× 46 0.9× 18 0.4× 67 1.5× 10 291
Joseph R. Magliozzi United States 11 164 1.1× 52 0.4× 46 0.9× 36 0.8× 63 1.4× 17 350

Countries citing papers authored by R. Kohnen

Since Specialization
Citations

This map shows the geographic impact of R. Kohnen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Kohnen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Kohnen more than expected).

Fields of papers citing papers by R. Kohnen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Kohnen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Kohnen. The network helps show where R. Kohnen may publish in the future.

Co-authorship network of co-authors of R. Kohnen

This figure shows the co-authorship network connecting the top 25 collaborators of R. Kohnen. A scholar is included among the top collaborators of R. Kohnen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Kohnen. R. Kohnen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Hummelsberger, J., et al.. (2015). Traditionelle chinesische Arzneitherapie bei Patienten mit chronischer Rhinosinusitis − eine Therapiebeobachtung mit Berücksichtigung der Arzneimittelherkunft. Complementary Medicine Research. 22(5). 312–319. 1 indexed citations
2.
Kohnen, R., et al.. (2008). Entscheidung zur Komplementärmedizin: sachorientiert oder irrational?. DMW - Deutsche Medizinische Wochenschrift. 121(50). 1553–1560. 1 indexed citations
3.
4.
Brinkhaus, Benno, Sophie Wildner, R. Klein, et al.. (2006). Standardised Chinese herbal medicine in the treatment of active Crohn's disease – a randomised controlled study. Focus on Alternative and Complementary Therapies. 11(s1). 24–25. 1 indexed citations
5.
Henkel, Verena, Roland Mergl, Antje‐Kathrin Allgaier, et al.. (2005). Treatment of depression with atypical features: A meta-analytic approach. Psychiatry Research. 141(1). 89–101. 95 indexed citations
6.
Wehmeier, Peter M., Michael Kluge, Athanasios Maras, et al.. (2005). Fluoxetine Versus Trimipramine in the Treatment of Depression in Geriatric Patients. Pharmacopsychiatry. 38(1). 13–16. 11 indexed citations
7.
Walter, Maggie C., Peter Reilich, R. Kohnen, et al.. (2002). Creatine monohydrate in myotonic dystrophy. Journal of Neurology. 249(12). 1717–1722. 44 indexed citations
8.
Wolf, Robert Christian, Wagner F. Gattaz, Athanasios Maras, et al.. (2001). Differential Effects of Trimipramine and Fluoxetine on Sleep in Geriatric Depression. Pharmacopsychiatry. 34(2). 60–65. 15 indexed citations
9.
Philipp, Michael, J. W. G. Tiller, Dina Baier, & R. Kohnen. (2000). Comparison of moclobemide with selective serotonin reuptake inhibitors (SSRIs) on sexual function in depressed adults. European Neuropsychopharmacology. 10(5). 305–314. 31 indexed citations
10.
11.
12.
Bauer, Karin & R. Kohnen. (1999). Der Druck der Erfahrung treibt die Sprache in die Dichtung: Bildlichkeit in Texten Herta Muller. The German Quarterly. 72(4). 421–421.
13.
Tiller, J. W. G., Michael Philipp, Dina Baier, & R. Kohnen. (1999). Frequency of sexual dysfunction in depressed adults and impact on quality of life. European Neuropsychopharmacology. 9. 248–248. 1 indexed citations
14.
Benkert, Otto, et al.. (1999). Rapid onset of therapeutic action in major depression: A comparative trial of mirtazapine and paroxetine. European Neuropsychopharmacology. 9. 229–230. 4 indexed citations
15.
Linden, Maureen, Dina Baier, Holger Gothe, & R. Kohnen. (1997). What Happens to Patients After the End of a Clinical Trial?. Pharmacopsychiatry. 30(S 1). 35–43. 5 indexed citations
16.
Philipp, Michael, R. Kohnen, & Otto Benkert. (1993). A comparison study of moclobemide and doxepin in major depression with special reference to effects on sexual dysfunction. International Clinical Psychopharmacology. 7(3). 149–154. 55 indexed citations
17.
Kohnen, R. & G. A. Lienert. (1980). Defining tranquilizers operationally by non additive effect in experimental stress situations. Psychopharmacology. 68(3). 291–294. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stephen T.H. Sokolov Breakdown of academic impact, for papers by Alana M. Burns Breakdown of academic impact, for papers by Helen Jeffriess Breakdown of academic impact, for papers by H.-J. Möller Breakdown of academic impact, for papers by Petros Malitas Breakdown of academic impact, for papers by Gillian Campling Breakdown of academic impact, for papers by Victor Bancila Breakdown of academic impact, for papers by Ilaria Matarazzo Breakdown of academic impact, for papers by Manoochehr Khatami Breakdown of academic impact, for papers by Joseph R. Magliozzi
Rankless by CCL
2026